Your browser doesn't support javascript.
loading
IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma.
Aghayev, Turan; Mazitova, Aleksandra M; Fang, Jennifer R; Peshkova, Iuliia O; Rausch, Matthew; Hung, Manhsin; White, Kerry F; Masia, Ricard; Titerina, Elizaveta K; Fatkhullina, Aliia R; Cousineau, Isabelle; Turcotte, Simon; Zhigarev, Dmitry; Marchenko, Anastasiia; Khoziainova, Svetlana; Makhov, Petr; Tan, Yin Fei; Kossenkov, Andrew V; Wiest, David L; Stagg, John; Wang, Xin Wei; Campbell, Kerry S; Dzutsev, Amiran K; Trinchieri, Giorgio; Hill, Jonathan A; Grivennikov, Sergei I; Koltsova, Ekaterina K.
Afiliação
  • Aghayev T; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Mazitova AM; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Fang JR; Cedars-Sinai Medical Center, Cedars-Sinai Cancer Institute, Department of Medicine, Department of Biomedical Sciences, Los Angeles, California.
  • Peshkova IO; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Rausch M; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Hung M; Surface Oncology Inc., Cambridge, Massachusetts.
  • White KF; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Masia R; Liver Cancer Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Titerina EK; Surface Oncology Inc., Cambridge, Massachusetts.
  • Fatkhullina AR; Surface Oncology Inc., Cambridge, Massachusetts.
  • Cousineau I; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Turcotte S; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Zhigarev D; Centre Hospitalier de l'Université de Montréal Research Center, Montreal, Quebec, Canada.
  • Marchenko A; Centre Hospitalier de l'Université de Montréal Research Center, Montreal, Quebec, Canada.
  • Khoziainova S; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Makhov P; Cedars-Sinai Medical Center, Cedars-Sinai Cancer Institute, Department of Medicine, Department of Biomedical Sciences, Los Angeles, California.
  • Tan YF; Cedars-Sinai Medical Center, Cedars-Sinai Cancer Institute, Department of Medicine, Department of Biomedical Sciences, Los Angeles, California.
  • Kossenkov AV; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Wiest DL; Genomics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Stagg J; Bioinformatics Facility, The Wistar Institute, Philadelphia, Pennsylvania.
  • Wang XW; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Campbell KS; Centre Hospitalier de l'Université de Montréal Research Center, Montreal, Quebec, Canada.
  • Dzutsev AK; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Trinchieri G; Liver Cancer Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Hill JA; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Grivennikov SI; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Koltsova EK; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Cancer Discov ; 12(8): 1960-1983, 2022 08 05.
Article em En | MEDLINE | ID: mdl-35723626

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Carcinoma Hepatocelular / Interleucina-27 / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Carcinoma Hepatocelular / Interleucina-27 / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos